|
Market Closed -
Nasdaq
21:00:00 18/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.3119 USD | -6.48% |
|
-2.65% | -68.81% |
| 09-02 | Needham Downgrades TScan Therapeutics to Hold From Buy | MT |
| 09-02 | Wedbush Downgrades TScan Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $5 | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -6.48% | -2.65% | -62.18% | -66.10% | -68.81% | -81.87% | -89.21% | -95.00% | - | 22.6M | |
| -0.31% | +5.79% | -4.29% | +55.76% | +76.52% | +48.93% | +97.53% | +4.99% | - | 70.89B | |
| +0.39% | +2.06% | +0.16% | +14.24% | +21.57% | +40.91% | +78.49% | +211.10% | +5,651.82% | 62.32B | |
| -3.21% | -7.27% | -6.59% | +25.26% | -31.05% | -17.73% | +351.98% | +348.10% | +723.61% | 27.07B | |
| +0.50% | +7.13% | +3.64% | +63.37% | +60.15% | +29.43% | +15.48% | -59.10% | - | 26.2B | |
| -2.64% | -0.69% | +3.57% | +5.69% | +0.90% | -0.26% | -11.90% | -73.26% | - | 24.78B | |
| +0.71% | +8.03% | +7.41% | +38.91% | +11.49% | +27.22% | -13.18% | -16.30% | +104.90% | 20.59B | |
| -1.26% | -7.81% | -15.71% | +23.49% | +178.50% | +169.33% | +302.38% | +1,409.96% | +716.06% | 15.52B | |
| -0.22% | +3.99% | +9.86% | +12.43% | +33.15% | +44.28% | +173.35% | +181.66% | +330.70% | 14.49B | |
| +0.73% | +1.71% | +39.24% | +29.82% | +2.06% | -7.18% | +886.19% | +179.78% | +200.00% | 14.14B | |
| +0.04% | -0.77% | -14.91% | +11.01% | +17.70% | -9.49% | +456.14% | - | - | 14.06B | |
| -0.54% | -0.56% | +1.36% | +5.10% | -8.73% | +20.59% | +224.93% | +550.26% | +5,296.14% | 12.35B | |
| -0.28% | +0.22% | -0.55% | +3.37% | -19.91% | -30.92% | +137.22% | +112.19% | - | 10.65B | |
| -1.63% | -6.76% | -9.62% | -12.69% | +8.25% | +39.54% | +103.07% | +102.95% | +696.06% | 9.72B | |
| -1.86% | -19.76% | -24.37% | -18.75% | +0.14% | +110.98% | +136.33% | +2.39% | +838.98% | 9.57B | |
| -3.71% | -2.25% | -2.78% | +13.01% | +25.99% | +78.37% | +14.45% | +129.22% | - | 8.98B | |
| +0.24% | +7.21% | +9.84% | +15.22% | +328.28% | +197.54% | +407.78% | -16.70% | - | 8.97B | |
| -2.62% | -0.39% | -16.30% | +2.16% | +175.49% | +489.10% | +627.24% | -51.67% | -53.18% | 8.17B | |
| +0.81% | +1.29% | -5.62% | +9.05% | +3.75% | -30.19% | +83.99% | -27.26% | - | 7.98B | |
| +0.36% | -1.63% | +5.16% | +17.00% | +6.88% | +133.39% | +443.42% | - | - | 6.86B | |
| Average | -1.08% | -0.62% | -4.13% | +12.37% | +41.12% | +62.60% | +221.28% | +160.74% | +1,450.51% | 18.67B | |
| Weighted average by Cap. | -0.61% | +0.40% | -0.77% | +25.45% | +42.16% | +49.32% | +178.08% | +157.97% | +2,436.07% |
- Stock Market
- Stocks
- TCRX Stock
- Sector TScan Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
